###begin article-title 0
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Role of the Transcription Factor Sox4 in Insulin Secretion and Impaired Glucose Tolerance
###end article-title 0
###begin p 1
###xml 42 61 42 61 <email xmlns:xlink="http://www.w3.org/1999/xlink">r.cox@har.mrc.ac.uk</email>
Corresponding author: Prof. Roger D. Cox, r.cox@har.mrc.ac.uk
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVES&#8212;</bold>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
OBJECTIVES- To identify, map, clone, and functionally validate a novel mouse model for impaired glucose tolerance and insulin secretion.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
RESEARCH DESIGN AND METHODS- Haploinsufficiency of the insulin receptor and associated mild insulin resistance has been used to sensitize an N-ethyl-N-nitrosourea (ENU) screen to identify novel mutations resulting in impaired glucose tolerance and diabetes. The new impaired glucose tolerance 4 (IGT4) model was selected using an intraperitoneal glucose tolerance test and inheritance of the phenotype confirmed by generation of backcross progeny. Segregation of the phenotype was correlated with genotype information to map the location of the gene and candidates sequenced for mutations. The function of the SRY-related high mobility group (HMG)-box 4 (Sox4) gene in insulin secretion was tested using another ENU allele and by small interfering RNA silencing in insulinoma cells.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 678 679 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 690 693 690 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 205 210 <span type="species:ncbi:10090">mouse</span>
RESULTS- We describe two allelic autosomal dominant mutations in the highly conserved HMG box of the transcription factor Sox4. Previously associated with pancreas development, Sox4 mutations in the adult mouse result in an insulin secretory defect, which exhibits impaired glucose tolerance in association with insulin receptor+/--induced insulin resistance. Elimination of the Sox4 transcript in INS1 and Min6 cells resulted in the abolition of glucose-stimulated insulin release similar to that observed for silencing of the key metabolic enzyme glucokinase. Intracellular calcium measurements in treated cells indicate that this defect lies downstream of the ATP-sensitive K+ channel (KATP channel) and calcium influx.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 203 206 200 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
CONCLUSIONS- IGT4 represents a novel digenic model of insulin resistance coupled with an insulin secretory defect. The Sox4 gene has a role in insulin secretion in the adult beta-cell downstream of the KATP channel.
###end p 6
###begin p 7
Published ahead of print at  on 13 May 2008.
###end p 7
###begin p 8
A.H. and H.F. contributed equally to this work.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 739 740 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 295 300 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:10090">mouse</span>
Type 2 diabetes is a heterogeneous metabolic disorder characterized by hyperglycemia resulting from defects in insulin action and/or insulin secretion with underlying genetic and environmental causes. There has been some success in identifying genetic factors underlying type 2 diabetes in some human populations (for example, calpain 10, PPARG, KCNJ11, TCF7L2, and ENPP1), and new whole-genome association studies are identifying further new candidates; however, many genes remain to be identified (1-8). One approach to identifying new genes is to use the mouse as a model. For example, using a combination of quantitative trait loci mapping and mutagenesis techniques, we recently identified a novel gene involved in insulin secretion (9-11).
###end p 10
###begin p 11
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 370 372 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 373 375 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 616 618 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 978 980 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 981 983 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1052 1054 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1391 1393 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1518 1520 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 1688 1692 1640 1644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 324 329 <span type="species:ncbi:10090">mouse</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
Phenotype-driven N-ethyl-N-nitrosourea (ENU) mutagenesis screens have proven to be a powerful and efficient tool for the identification of novel models of human disease (12,13). Mutations are introduced at a rate of approximately1/1,000 (one functional mutation at any one locus in 1,000 mice), and each founder mutagenized mouse carries approximately30 such mutations (14-16). ENU is an alkylating agent that preferentially induces A/T to T/A transversion mutations at random across the genome; these point mutations can create a variety of alleles, including hypomorphs, hypermorphs, and loss or gain of function (17). Thus, ENU could be used to introduce mutations into potentially any gene in the genome that can be mutated to give rise to diabetes or diabetes-related traits such as glucose intolerance. As an example, new ENU-induced dominant mutations in the key metabolic enzyme glucokinase (maturity onset diabetes of the young 2 [MODY2]) have recently been described (18,19) from large-scale dominant ENU mutagenesis screens. Bruning et al. (20) showed that double heterozygotes of null alleles of the insulin receptor and insulin receptor substrate-1 led to the development of overt diabetes in approximately40% of animals in contrast to single heterozygotes. Diabetes development was dependent on genetic background with C57BL/6J showing approximately85% transition to diabetes (21). We therefore decided to sensitize our ENU mutagenesis screen by using mice heterozygous for an insulin receptor knockout (22) maintained on a C57BL/6J background, which exhibits mild insulin resistance but not diabetes. Here, we describe two ENU-induced mutations in the transcription factor Sox4 that result in impaired glucose-stimulated insulin release leading to a mild impairment in glucose tolerance, and we also show that one of these in combination with haploinsufficiency of the insulin receptor and associated insulin resistance provide a novel digenic model that may have relevance to the study of polygenic type 2 diabetes.
###end p 11
###begin p 12
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 213 217 <span type="species:ncbi:10090">Mice</span>
The SRY-related high mobility group (HMG)-box (SOX) gene family is a group of important transcriptional regulators of a number of developmental processes, including the development of the endocrine pancreas (23). Mice homozygous for a null mutation of Sox4 showed abnormal pancreatic bud formation and endocrine cell differentiation, and cultured pancreatic explants failed to form normal islets. In wild-type animals, levels of Sox4 expression peaked at embryonic day 13 and persisted at high levels in adult islets. No role has yet been elucidated for Sox4 in the adult pancreas.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin title 14
Animal husbandry.
###end title 14
###begin p 15
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
Mice were kept in accordance with U.K. Home Office welfare guidelines and project license restrictions. Insulin receptor knockout mice (22) were obtained from The Jackson Laboratories (Bar Harbor, ME) and maintained as heterozygotes on a C57BL/6J background. MUD91 mice (a line carrying an ENU-induced Sox4 allele from a developmental abnormality screen) maintained on a mixed genetic background have been previously reported (24).
###end p 15
###begin title 16
ENU mutagenesis.
###end title 16
###begin p 17
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
Male mice heterozygous for the insulin receptor knockout mutation were treated with 2 x 100 mg/kg doses of ENU at 7-day intervals (12). Lines were maintained by back-crossing to C3H/HeH mice.
###end p 17
###begin title 18
Genotyping.
###end title 18
###begin p 19
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 233 238 <span type="species:ncbi:10090">mouse</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
Genomic DNA was extracted from mouse tail tissue using a DNeasy tissue kit (Qiagen, West Sussex, U.K.) according to the manufacturer's instructions. A genome scan was performed with a panel of 140 microsatellite markers spanning the mouse genome. Insulin receptor knockout mice were genotyped using a generic neo PCR (The Jackson Laboratories). Genotypes for both Sox4 alleles were confirmed by sequencing, and gene fragments were amplified using the following primers listed in a 5'-3' orientation and sequenced: Y123C, GCAAGATCATGGAGCAGTC (SOX4F2) and GAGAACGATGCAGCCG (SOX4Rbio); and S70P, GAGCACTTCAGCGGTGA (SOX4F1) and GGAGATCTCGGCCGTTGT (SOX4R1).
###end p 19
###begin title 20
Micro-magnetic resonance imaging.
###end title 20
###begin p 21
Embryos were dissected at 14.5 days post coitum (dpc) into 37degreesC Hanks solution plus 5.0 mmol/l EDTA and allowed to exsanguinate. Embryos were then fixed in 4% paraformaldehyde in PBS plus 2 mmol/l dimeglumine gadopentetate (Gd-DPTA; Magnevist) for several days at 4degreesC. Before magnetic resonance imaging (MRI), the fixed embryos were embedded in 1% agarose in water with 2 mmol/l Gd-DPTA in 13-mm (high-resolution single-embryo imaging) glass tubes. MRI was performed at an experimental resolution of 9.7 x 9.7 x 12.7 m/voxel. MRI images were archived as TIFF files on DVD and analyzed using AMIRA 4.1 software.
###end p 21
###begin title 22
Intraperitoneal glucose tolerance tests.
###end title 22
###begin p 23
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 497 502 <span type="species:ncbi:10090">Mouse</span>
Mice were tested using the EMPReSS simplified intraperitoneal glucose tolerance test (IPGTT) (). Briefly, mice were fasted overnight, and a fasted blood sample was taken before intraperitoneal administration of a 2 g/kg glucose load. Subsequent blood samples were taken over time (60 and 120 min for glucose measurements or 10, 20, and 30 min for insulin measurements). Plasma glucose was measured using an Analox Glucose Analyser GM9. Plasma insulin was measured using a Mercodia Ultra-Sensitive Mouse ELISA kit (Mercodia, Uppsala, Sweden) according to the manufacturer's instructions.
###end p 23
###begin title 24
INS1 and Min6 cell culture.
###end title 24
###begin p 25
###xml 275 276 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 165 171 <span type="species:ncbi:9913">bovine</span>
INS-1 cells (starting passage 30) were maintained in RPMI 1640 containing 5.5 mmol/l glucose (Gibco, Paisley, U.K.) and supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, and 100 mug/ml streptomycin. Cells were incubated in humidified 5% CO2, 95% air at 37degreesC.
###end p 25
###begin p 26
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
MIN6 cells (starting passage 30) were maintained in Dulbecco's modified Eagle's medium containing 25 mmol/l glucose and supplemented with 15% heat-inactivated FBS in humidified 5% CO2, 95% air at 37degreesC.
###end p 26
###begin title 27
Islet isolation.
###end title 27
###begin p 28
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 226 227 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed by cervical dislocation, the pancreases were removed, and islets were isolated by liberase digestion and handpicking (25). Cells were maintained in this medium at 37degreesC in a humidified atmosphere at 5% CO2 in air and used 1-2 days after the isolation.
###end p 28
###begin title 29
Small interfering RNA.
###end title 29
###begin p 30
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Synthetic small interfering RNAs (siRNAs) were designed by Ambion and synthesized by both Ambion and Eurogentec. A total of four siRNAs were used: nonsense, glucokinase (Gck), and two Sox4 siRNAs. Each siRNA had a Cy3 tag on the 5' end of the sense strand to enable visualization of transfected cells. siRNA duplexes (500 nmol/l) were transfected into INS1 and MIN6 cells using Lipofectamine 2000 (Invitrogen, Paisley, U.K.) at 100 mumol/l. Cells were cultured in RPMI 1640 (FBS free) for a further 24 h before experiment. siRNA sequences used listed in a 5' to 3' orientation as follows: Sox4(1), 'GGACAGCGACAAGAUUCCGtt' (forward) and 'CGGAAUCUUGUCGCUGUCCtt' (reverse); Sox4(2), 'GGAGAGGAGAGAGGGAAAAtt' (forward) and 'UUUUCCCUCUCUCCUCUCCtg' (reverse); Gck, 'ACGUAGGUGGGCAACAUCUtt' (forward) and 'AGAUGUUGCCCACCUACGUtt' (reverse); and Nonsense, 'GGUCUAGUCUUCGGUCUUGtt' (forward) and 'CAAGACCGAAGACUAGACCtt' (reverse).
###end p 30
###begin title 31
Fura-2 calcium imaging.
###end title 31
###begin p 32
###xml 592 593 579 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 610 611 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
INS1 cells were cultured on 35-mm Fluorodishes (World Precision Instruments) and incubated with 3 mumol/l Fura-2-AM (Molecular Probes) for 40 min at 37degreesC. They were imaged at room temperature (20-24degreesC) using an IonOptix fluorescence system (IonOptix, Boston, MA), with 340- and 380-nm dual excitation. The 510-nm emission ratio was collected at 1 Hz. Background subtraction was performed by measuring fluorescence from a cell-free region in the field of view. Cells were perfused continuously with extracellular solution containing 137 mmol/l NaCl, 5.6 mmol/l KCl, 2.6 mmol/l CaCl2, 1.2 mmol/l MgCl2, and 10 mmol/l HEPES (pH 7.4 with NaOH) plus glucose or tolbutamide as indicated. Only data from cells that responded to 200 mumol/l tolbutamide were analyzed.
###end p 32
###begin title 33
Insulin secretion.
###end title 33
###begin p 34
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 430 431 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 447 448 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 450 451 450 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 485 486 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 896 901 <span type="species:ncbi:10090">Mouse</span>
INS1 or Min6 cells (1 x 105) were re-plated, transfected with various siRNAs, and cultured for 24 h (as above) before being used in secretion assays. Islets were isolated from wild-type and mutant mice and cultured overnight (as described above) before insulin secretion was assessed. Insulin secretion per group of five islets was measured during 1-h static incubations in Krebs-Ringer buffer (118.5 mmol/l NaCl, 2.54 mmol/l CaCl2, 1.19 mmol/l KH2PO4, 4.74 mmol/l KCl, 25 mmol/l NaHCO3, 1.19 mmol/l MgSO4, and 10 mmol/l HEPES, pH 7.4) containing 0, 2, or 20 mmol/l glucose or 0.2 mmol/l tolbutamide in the presence of 2 mmol/l glucose. Each glucose concentration was replicated three times per individual. Samples of the supernatant were assayed for insulin. To determine total insulin content, insulin was extracted using 95:5 ethanol:acetic acid. Insulin was measured using an Ultra-Sensitive Mouse Insulin ELISA kit (Mecodia).
###end p 34
###begin title 35
Quantitative RT-PCR.
###end title 35
###begin p 36
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
Total RNA from isolated islets and siRNA-transfected INS1 and MIN6 cells was extracted using a RNeasy mini-kit (Qiagen). cDNA generated by Superscript II enzyme (Invitrogen) was analyzed by quantitative RT-PCR using the TaqMan system based on real-time detection of accumulated fluorescence (ABI Prism 7700; Perkin-Elmer). Gene expression was normalized relative to the expression of glyceraldehyde-3-phosphate dehydrogenase (Gapdh). Inventoried Taqman Probes with FAM tags were purchased from Applied Biosystems.
###end p 36
###begin p 37
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 253 259 253 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Camk2b</italic>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdc42</italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut2</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpx-1</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins2</italic>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kir6.2</italic>
###xml 309 316 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NeuroD1</italic>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx6.1</italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDX1</italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkci</italic>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab27</italic>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sur1</italic>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syt9</italic>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab27</italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syt9</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 725 728 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Samples were tested in triplicate, and results are expressed relative to Gapdh. The Student's t test was used to measure the significance between wild-type and Sox4 heterozygous islet cDNA (three biological replicates for each group) when amplified for Camk2b, Cdc42, Glut2, Glut4, Gpx-1, Ins1, Ins2, Kir6.2, NeuroD1, Nkx6.1, Pax6, PDX1, Prkci, Rab27, Sox4, Sur1, and Syt9 gene expression. Islet cDNA amplified for Glut4, Rab27, and Syt9 was first preamplified using a Taqman PreAmp Master Mix (Applied Biosystems). The Student's t test was also used to measure the significance between nonsense siRNA-transfected INS1 cells, Gck siRNA-transfected INS1 cells, and Sox4 siRNA-transfected INS1 cells when amplifying for either Gck or Sox4 gene expression.
###end p 37
###begin title 38
Complementation test and embryonic phenotype analysis.
###end title 38
###begin p 39
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 134 148 134 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Del(13)Svea36H</italic>
Males heterozygous for the Y123C Sox4 mutation were crossed to females heterozygous for the same mutation, the S70P mutation, and the Del(13)Svea36H deletion. Embryo dissections were carried out at 9.5, 13.5, and 14.5 dpc, and the embryonic phenotype was visually analyzed. Tissue was collected from individual embryos and the samples genotyped by sequencing as described above.
###end p 39
###begin title 40
Electron microscopy.
###end title 40
###begin p 41
After preparation (see above), isolated islets (30-40 per animal) were left to recover in pancreatic islet medium (hCell Technology) for 1 h at 37degreesC. Islets were then washed in PBS and fixed in cold 2.5% glutaraldehyde in PBS for 1 h at 4degreesC, after which they were washed twice in PBS. Osmium tetroxide at 1% in PBS was then added to the islets for 1 h at 4degreesC, followed by washing twice with PBS. The islets were then left in PBS at 4degreesC overnight. Finally, islets were dehydrated in increasing concentrations of ethanol (50, 70, 90, and 100%) for 5-10 min each and then embedded in increasing concentrations of resin (50% ethanol/50% Agar 100 resin mix [48% Agar 100 resin, 26% dodecenyl succinic anhydride, 26% methyl nadic anhydride; Agar Scientific], 25% ethanol/75% resin, and 100% resin) for 5-10 min each. Islets were left in 100% resin (resin plus 2% benzyl dimethylamine) at least overnight at room temperature before ultra-thin sections were cut for electron microscopy.
###end p 41
###begin title 42
Islet immunohistochemistry.
###end title 42
###begin p 43
###xml 85 91 <span type="species:ncbi:9986">rabbit</span>
###xml 95 99 <span type="species:ncbi:9925">goat</span>
###xml 274 280 <span type="species:ncbi:9986">rabbit</span>
###xml 328 334 <span type="species:ncbi:9986">rabbit</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 376 382 <span type="species:ncbi:9986">rabbit</span>
###xml 437 443 <span type="species:ncbi:9986">rabbit</span>
###xml 470 474 <span type="species:ncbi:9925">goat</span>
###xml 522 526 <span type="species:ncbi:9925">goat</span>
###xml 573 579 <span type="species:ncbi:9986">rabbit</span>
###xml 622 628 <span type="species:ncbi:9986">rabbit</span>
Immunohistochemistry was carried out on paraffin sections of 17-week-old pancreas. A rabbit or goat (depending on primary antibody) ABC staining system (Santa Cruz Biotechnology) was used according to manufacturer's instructions. The following primary antibodies were used: rabbit anti-insulin (1:50; Santa Cruz Biotechnology), rabbit anti-human glucagon (1:40; AbD Serotec), rabbit anti-somatostatin (2 mug/ml; Chemicon International), rabbit anti-PDX1 (1:500; Abcam), goat anti-Nkx-6.1 (1:50; Santa Cruz Biotechnology), goat anti-NeuroD (1:50; Santa Cruz Biotechnology), rabbit anti-MafA (1:500; Bethyl Laboratory), and rabbit anti-Glut2 (1:2,000; Chemicon International). Sections were counterstained with Gill's formulation no. 2 hematoxylin.
###end p 43
###begin title 44
Islet area analysis.
###end title 44
###begin p 45
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 393 398 <span type="species:ncbi:10090">mouse</span>
The pancreas from each mouse was fixed in neutral buffered formaldehyde (Surgipath Europe) and mounted in wax longitudinally using the spleen for orientation. Serial sections were cut from each pancreas, and every 20th section was stained with hematoxylin-eosin (H-E) (mounting, cutting, and staining was carried out by Medical Solutions, Nottingham, U.K.). Ten H-E-stained sections from each mouse were photographed completely, and islet area calculated using Adobe Photoshop to measure islet area and total pancreas section area in each image.
###end p 45
###begin title 46
RESULTS
###end title 46
###begin title 47
Sensitized ENU mutagenesis screen.
###end title 47
###begin p 48
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
Haploinsufficiency of the insulin receptor leading to insulin resistance but not diabetes was used for a sensitized ENU phenotype-driven screen. Male INSR+/- mice heterozygous for the insulin receptor knockout (insulin receptor+/-) on a C57BL/6J genetic background were treated with two doses of 100 mg/kg ENU separated by 7 days. Upon regaining fertility, they were mated with C3H/HeH females, and up to 50 F1 offspring per male were generated. A total of 789 male F1 offspring heterozygous for the insulin receptor knockout mutation were assayed for glucose tolerance at 12 and 24 weeks of age by IPGTT. Fourteen male mice were identified with impaired glucose tolerance and were tested for inheritance of the phenotype by backcrossing to C3H/HeH females (impaired glucose tolerance [IGT] lines 1-14). Five phenotypes were confirmed as inherited in the first backcross generation (data not shown).
###end p 48
###begin title 49
Mapping line IGT4 and identification of a mutation.
###end title 49
###begin p 50
###xml 913 917 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 919 925 919 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 627 632 <span type="species:ncbi:10090">mouse</span>
One of the lines clearly associated with an impaired glucose tolerance phenotype was IGT4. The causative mutation was initially mapped to chromosome 13 using 16 backcross animals and a panel of 140 microsatellite markers. An additional 67 second-backcross animals refined the candidate region to 5.4 Mb (25.9-31.3 Mbp). Analysis of the candidate region using the Ensembl database ( Build 27) identified 39 genes, including a large cluster of prolactin-like genes that were excluded from analysis because they are unlikely candidates for a glucose tolerance phenotype. The remaining eight genes were sequenced in the F1 founder mouse to identify the ENU-induced causative mutation. A single A to G mutation was found at nucleotide position 1,025 (A1025G), resulting in a tyrosine to cysteine substitution at amino acid 123 (Y123C), which lies in the highly conserved HMG-binding domain of the transcription factor Sox4 (Fig. 1).
###end p 50
###begin title 51
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Sox4 homozygous mutant mice have an embryonic-lethal phenotype.
###end title 51
###begin p 52
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 483 489 483 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
Embryos homozygous for the IGT4 Sox4 Y123C mutation die in utero at 14.5 dpc. An additional mutant allele of Sox4 (MUD91) carrying a T to C transition at nucleotide 869 (T869C), resulting in a serine to proline substitution at amino acid 70 (S70P), was available from a developmental phenotype screen at Harwell (24). Both mutations alter highly conserved amino acids within the HMG binding domain of Sox4 and are predicted to abolish the DNA binding ability of the mutant proteins (Fig. 1). Embryos homozygous for Mud91 Sox4 S70P die in utero at 14.5 dpc because of circulatory failure (24).
###end p 52
###begin p 53
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 403 411 403 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 454 468 454 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Del(13)Svea36H</italic>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ox4</italic>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 600 608 600 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 651 654 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Del</italic>
###xml 655 657 655 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">13</italic>
###xml 658 665 658 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Svea36H</italic>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
Analysis of the embryonic phenotype shows no difference between embryos homozygous for either of the two alleles. We therefore decided to test whether the two mutations complement each other by breeding compound heterozygotes. We found that Y123C/S70P mice exhibit the same embryonic phenotype as the homozygotes for either mutation (Table 1). We also tested the IGT4 Sox4 Y123C mutation by breeding it in trans with a deletion that spans the Sox4 gene (Del(13)Svea36H) and again observed embryonic lethality indistinguishable from that of the two homozygous Sox4 mutants. The Mud91 Sox4 S70P allele in trans with a deletion that spans the Sox4 gene (Del(13)Svea36H) was previously shown to be embryonic lethal (26).
###end p 53
###begin p 54
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Del</italic>
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">13</italic>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Svea36H</italic>
###xml 153 157 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 164 167 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Del</italic>
###xml 168 170 167 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">13</italic>
###xml 171 178 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Svea36H</italic>
###xml 210 216 209 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 414 420 412 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 435 439 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 446 460 444 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Del(13)Svea36H</italic>
###xml 664 668 662 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 758 762 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 769 771 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 880 884 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 986 990 984 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1009 1011 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1012 1014 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
To further ascertain the nature of the IGT4 cardiac phenotype, we analyzed IGT4 Sox4 Y123C/Del(13)Svea36H embryos at 14.5 dpc by micro-MRI (muMRI). IGT4 Sox4 Y123C/Del(13)Svea36H embryos showed external edema (Fig. 2). Cardiac defects observed by muMRI included an outlet ventricular septal defect, dysplastic atrioventricular valves, a double-outlet right ventricle, and a hypoplastic or interrupted aortic arch (Fig. 2). Of the IGT4 Sox4 Y123C/Del(13)Svea36H embryos, 60% also showed a cleft palate, and on one occasion we found bilateral renal hypoplasia and bilateral hypoplasia of the thymus. Apart from a primum atrial septal defect, only found in the Mud91 Sox4 S70P, these MRI results are consistent with the findings in embryos homozygous for Mud91 Sox4 S70P (24). The results are a phenocopy of the range of cardiac defects previously detected in the targeted allele of Sox4, but additionally we detected dysplastic atrioventricular valves that have not been described in the Sox4 knockout embryos (27,28).
###end p 54
###begin p 55
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 237 245 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans</italic>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
The failure of these mutations to complement either each other or a deletion of the Sox4 gene demonstrates that IGT4 Sox4 Y123C mutation affects gene function. Moreover, the fact that the mutation gives the same embryonic phenotype when in trans with a deletion suggests that IGT4 Sox4 Y123C mutation is a null.
###end p 55
###begin title 56
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Sox4 heterozygous mutant mice show impaired glucose tolerance and reduced insulin secretion.
###end title 56
###begin p 57
###xml 195 198 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 455 456 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 528 532 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 584 588 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 637 638 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 631 638 627 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 670 674 666 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 846 849 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 899 900 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 992 993 988 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 998 999 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 986 999 982 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic> and <italic>B</italic></xref>
###xml 1071 1075 1067 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1167 1171 1163 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1224 1227 1220 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1352 1355 1348 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1372 1373 1368 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1366 1373 1362 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1526 1530 1522 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1615 1618 1611 1614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1763 1764 1759 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1769 1770 1765 1766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1757 1770 1753 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic> and <italic>D</italic></xref>
###xml 1836 1837 1832 1833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1830 1837 1826 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 1855 1856 1851 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1924 1925 1920 1921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1918 1925 1914 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 2008 2009 2004 2005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
Glucose tolerance was assayed using an IPGTT with glucose measured at 0 min (T0), 60 min (T60), and 120 min (T120). Male mice heterozygous for both the insulin receptor knockout (insulin receptor+/-) and the IGT4 Sox4 Y123C mutant allele exhibited impaired glucose tolerance in an IPGTT test at 12 weeks of age (Fig. 3A). Glucose levels were significantly different from wild-type or insulin receptor+/- littermates at all three time points examined (T0, P < 0.05; T60, </=0.001; and T120, </=0.001). The existence of the Mud91 Sox4 S70P allele allowed us to test whether a different Sox4 mutation also affected glucose tolerance (Fig. 3B). Inheritance of either of the Sox4 mutant alleles (Y123C or S70P) alone and in the absence of the insulin receptor mutation increased glucose levels significantly compared with wild-type or insulin receptor+/- littermates 60 min after glucose administration (P < 0.05), with levels failing to return to normal levels in Y123C mice after 120 min (Fig. 3A and B). Glucose intolerance observed in two independently derived alleles of Sox4 confirms that the phenotype is caused by the identified mutations. In the case of the IGT4 Sox4 Y123C mutation, the presence of the insulin receptor+/- significantly increased blood glucose concentrations in an IPGTT, demonstrating a sensitizing effect of the insulin receptor+/- knockout (Fig. 3A). To investigate whether there was a defect in insulin secretion that might account for the glucose intolerance, we measured insulin secretion for both Sox4 alleles (Y123C or S70P). This was carried out in the absence of the insulin receptor+/- mutation using a 30-min glucose tolerance test with blood samples taken and glucose and insulin levels measured at T0, T10, T20, and T30 (Fig. 3C and D). Both lines showed significantly elevated glucose levels (Fig. 3C) at T20 and T30 (P < 0.001) and secreted significantly lower levels of insulin (Fig. 3D) in response to a glucose challenge compared with wild type at T10, T20, and T30 (P < 0.01).
###end p 57
###begin p 58
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 560 566 560 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 769 770 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 782 785 782 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 873 877 873 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 923 926 923 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1103 1104 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1097 1104 1097 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 1183 1184 1183 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
To further confirm a defect in insulin secretion, we measured glucose-stimulated insulin secretion in isolated islets from mice carrying the IGT4 Sox4 Y123C mutation (Fig. 4). Basal insulin secretion was the same as wild-type littermate control islets. However, incubation in 20 mmol/l glucose stimulated significantly less insulin secretion from mutant compared with wild-type littermate islets (P < 0.05). Furthermore, the response to the sulfonylurea tolbutamide was also significantly impaired, but not to the same extent as observed in 20 mmol/l glucose (Fig. 4). There was no significant difference in total insulin content between mutant and wild-type islets (Supplemental Fig. 1, available in the online appendix at ). Because tolbutamide closes ATP-sensitive K+ channels (KATP channels) directly, this result suggests that the insulin secretory defect observed in Sox4 heterozygous mutant mice lies downstream of KATP channel closure. Insulin secretion in insulin receptor heterozygous controls was significantly higher at all points, consistent with increased in vivo insulin secretion (Fig. 3D). Additionally, insulin receptor islets showed reduced total insulin content (P < 0.001; Supplemental Fig. 1).
###end p 58
###begin title 59
Sox4 heterozygous animals form normal islets.
###end title 59
###begin p 60
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 499 505 488 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 556 560 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 744 748 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 792 793 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
Pancreatic sections from Sox4-heterozygous animals and wild-type littermates were examined for differences in both islet mass and architecture. There was no significant difference between wild-type and heterozygous IGT4 Sox4 Y123C mice in their percentage of islet areas (the percentage of a histological section identified as islet; Table 2). Histological staining showed no qualitative difference in islet architecture in terms of arrangement or relative numbers of alpha-, beta-, or delta-cells (Fig. 5). Transmission electron microscopy of islets from Sox4-heterozygous animals and wild-type littermates at 12 weeks of age showed no obvious differences (Supplemental Fig. 2). Quantitative RT-PCR analysis of islet RNA showed an increase in Sox4 expression that just reaches significance (P = 0.045) and no difference in expression levels of a number of key beta-cell target genes, including insulin (Supplemental Fig. 3).
###end p 60
###begin title 61
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
siRNA knockdown of Sox4 in INS1 cells.
###end title 61
###begin p 62
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 631 634 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 782 783 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 788 789 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 776 789 776 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic> and <italic>B</italic></xref>
###xml 862 863 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 856 863 856 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1256 1260 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1288 1291 1288 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 1340 1341 1340 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1334 1341 1334 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1404 1408 1404 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1540 1543 1540 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 1569 1570 1569 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1563 1570 1563 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1621 1625 1621 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1641 1647 1641 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 1694 1699 <span type="species:ncbi:10090">mouse</span>
To further validate the in vivo and isolated islet data, we investigated the effect of loss of Sox4 gene expression in a rat insulin-secreting cell line INS1 using RNA interference (siRNA) to knock down the expression of the endogenous Sox4 gene. INS1 cells were transfected with one of four siRNA duplexes: nonsense (negative control), Gck (positive control), or two different Sox4-specific siRNAs [Sox4(1) and Sox4(2)]). All siRNAs were tagged with Cy3 fluorescent dye to enable transfected cells to be easily detected. Gene-specific knockdown of the corresponding RNAs was confirmed by quantitative real-time PCR. Expression of Gck and Sox4 mRNAs was abolished by siRNAs targeted against these genes, but neither was affected in INS1 cells transfected with nonsense siRNA (Fig. 6A and B). Basal insulin secretion was the same for all transfected cells (Fig. 6C), and siRNA knockdown had no effect on total insulin content compared with nonsense transfected cells (Supplemental Fig. 4). Nonsense siRNA-transfected INS1 cells responded to incubation in both 2 and 20 mmol/l glucose by secreting increasing amounts of insulin. In comparison, glucose-stimulated insulin secretion at 2 and 20 mmol/l glucose was significantly reduced for both nonoverlapping Sox4 siRNA duplexes and for the Gck-positive control compared with wild type (Fig. 6C). There was a significant reduction in insulin secretion from Sox4 siRNA-transfected INS1 cells in response to tolbutamide compared with nonsense siRNA-transfected cells. This was not observed with Gck-transfected cells (Fig. 6C). These results resemble those found for isolated Sox4 mutant islets (Fig. 4). These experiments have been repeated in the mouse insulinoma cell line Min6 with the same results (Supplemental Figs. 4-6).
###end p 62
###begin title 63
Intracellular calcium measurements.
###end title 63
###begin p 64
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 172 174 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 362 364 362 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 365 366 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 442 448 442 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7</xref>
###xml 520 523 520 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
To further characterize the glucose-stimulated insulin secretory defect in Sox4 siRNA-transfected INS1 cells, we measured changes in intracellular calcium concentration [Ca2+]i in response to incubation in increasing glucose concentrations. In Sox4 (duplexes 1 and 2), nonsense, and mock-transfected cells, glucose concentrations >2 mmol/l elicited a rise in [Ca2+]i, and this was abolished, as expected, in cells transfected with Gck siRNA (Fig. 7). These data suggest that the secretory defect lies downstream of the KATP channels, calcium influx that follows channel closure, and membrane depolarization.
###end p 64
###begin title 65
DISCUSSION
###end title 65
###begin p 66
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 357 359 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 403 407 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 424 428 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 516 520 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 827 829 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 844 848 841 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Sox4 is a transcription factor that is expressed in the pancreas (29,23). Embryos null for Sox4 show normal pancreatic bud formation and endocrine cell differentiation up to 12.5 dpc (23). However, after this stage, they failed to form normal islets, and there was a lack of proper expansion of the endocrine cell population and particularly of beta-cells (23). Breeding of compound heterozygotes (IGT4 Sox4 Y123C and Mud91 Sox4 S70P) and crossing both alleles with the chromosome deletion del36H confirms that both Sox4 mutations, as predicted, affect the function of the protein. The observation of glucose intolerance in the two independent heterozygous ENU alleles also confirms that the ENU mutation accounts for the phenotype, and the likelihood of other ENU mutations being present within the mapped region is very low (16). The role of Sox4 in the adult islet is unknown.
###end p 66
###begin p 67
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
###xml 388 392 <span type="species:ncbi:10090">Mice</span>
Random ENU mutagenesis has proven to be an effective tool in the identification of novel mouse models of human disease (12,13). In our sensitized approach, which used a mouse knockout exhibiting insulin resistance but not diabetes and a sensitive phenotypic assay (IPGTT), we have successfully identified a novel mouse model for impaired glucose tolerance and cloned the underlying gene. Mice heterozygous for either ENU mutated allele of Sox4 (Y123C or S70P) exhibited a statistically significant impairment in glucose tolerance at 12 weeks of age.
###end p 67
###begin p 68
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
IPGTT testing of mice heterozygous for a null mutation of Sox4 has been reported to have nonsignificant differences in glucose tolerance at the 30-min time point of the test; however, there was a clear trend of increased blood glucose concentrations in heterozygotes at all of the IPGTT time points after fasting shown (23). It should be noted that the genetic background of these mice is different. Furthermore, Wilson et al. (23) carried out IPGTT tests using a 1 g/kg glucose challenge, lower than the 2 g/kg that we used, and this may have also contributed to the differences we observed.
###end p 68
###begin p 69
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 534 536 534 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 537 538 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 618 621 618 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
Both ENU-induced mutations in Sox4 (S70P and Y123C) were significantly glucose intolerant because of impaired glucose-stimulated insulin secretion. This reduction in glucose-stimulated insulin release was also observed in isolated islets from IGT4 Sox4 Y123C mutant mice when compared with wild-type littermates. Knockdown of Sox4 in insulinoma cells with two different siRNAs targeted to separate regions of the gene abolished glucose-stimulated insulin release, as did siRNA knockdown of the key metabolic enzyme Gck. Changes in [Ca2+]i evoked by glucose, however, were normal in Sox4 mutant cells, indicating that KATP channels close normally. This suggests the insulin secretory defect lies downstream of calcium signal and may represent, for example, a defect in triggering exocytosis. Electron microscopy analysis, however, did not reveal any gross abnormalities in vesicles or their distribution.
###end p 69
###begin p 70
###xml 78 81 75 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 280 282 277 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 283 284 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 435 439 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 548 551 545 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 725 732 722 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Figs. 4</xref>
###xml 737 738 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">6</xref>
###xml 960 963 957 960 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1070 1074 1067 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1137 1139 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
Tolbutamide stimulates insulin secretion in pancreatic beta-cells by closing KATP channels in the plasma membrane directly, leading to membrane depolarization and activation of voltage-gated calcium channels. This results in calcium influx and a rise in intracellular calcium ([Ca2+]i) that triggers insulin release. We observed a significant reduction in tolbutamide-stimulated insulin secretion both in isolated mutant islets and in Sox4 siRNA-treated INS1 or Min6 cells compared with wild-type cells, consistent with a defect downstream of the KATP channel. However, insulin secretion by mutant islets or siRNA-treated insulinoma cells was significantly more stimulated by tolbutamide than by 20 mmol/l glucose treatment (Figs. 4 and 6; Supplemental Fig. 5). It is known that at higher tolbutamide concentrations, there is stimulation of insulin exocytosis by direct interaction with the secretory machinery independently of closure of the plasma membrane KATP channel. This mechanism may explain why the inhibition of tolbutamide-stimulated insulin secretion by the Sox4 mutation is not as strong as that observed for glucose alone (30).
###end p 70
###begin p 71
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 602 604 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 624 626 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 669 674 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxo1</italic>
###xml 765 769 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1018 1021 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1134 1137 1125 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1395 1397 1386 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
The glucose intolerance caused by the IGT4 Sox4 Y123C mutation is made worse by the presence of the heterozygous insulin receptor null mutation. This may in part be a contribution of insulin receptor haploinsufficiency to insulin resistance in key tissues, such as liver, adipose tissue, and muscle, that reduces glucose tolerance, further compounding lower glucose-stimulated insulin secretion. However, the insulin receptor is important in beta-cell function, as shown by tissue-specific knockout of this gene that results in decreased acute insulin secretion and in impairment of glucose tolerance (31). Martinez et al. (32) have shown that the transcription factor Foxo1 is regulated in the beta-cell by glucose but that this requires the insulin receptor. The Sox4 mutations outlined in this work have an effect on glucose-stimulated insulin secretion in the absence of the insulin receptor heterozygous null mutation, so although we cannot rule out a sensitizing effect in the beta-cell when the insulin receptor+/- mutation is present, it is not a requirement for impairment. The IGT4 model in combination with insulin receptor+/- shows the effect of multiple mutations on glucose intolerance. This is important because it is thought that multiple variants in susceptibility genes contribute to impairment of glucose homeostasis in diabetes through the sum of multiple negative variants (33).
###end p 71
###begin p 72
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
Interestingly, insulin receptor+/- heterozygotes secrete more insulin and have lower isolated islet insulin content. This may reflect the higher levels of secretion as a result of insulin resistance.
###end p 72
###begin p 73
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Sox proteins are dependent on other transcription factors as partner proteins for efficient gene activation (34,35). Specificity of Sox proteins are therefore reliant on different binding partners, which may explain the diverse roles in different tissues and developmental stages (36). Elucidation of the binding partner of Sox4 in adult islets may lead to the identification of the genes it regulates.
###end p 73
###begin p 74
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox17</italic>
###xml 142 146 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF4</italic>
###xml 217 221 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 272 276 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF4</italic>
###xml 344 348 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF4</italic>
###xml 471 477 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 482 485 470 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt</italic>
###xml 526 528 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
Sinner et al. (37) have recently reported that in colon carcinoma cells, there is an interaction between Sox4 and Sox17 with beta-catenin and TCF4. They propose a role for these Sox genes in regulating Wnt signaling. Sox4 was shown to interact with either beta-catenin or TCF4. In contrast, Sox17 bound cooperatively with both beta-catenin and TCF4. It will be very interesting to determine whether these interactions are found in the beta-cell, given the implication of TCF7L2 and Wnt signaling in insulin secretion (rev. in 38).
###end p 74
###begin p 75
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 408 412 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 462 468 <span type="species:ncbi:9606">humans</span>
Type 2 diabetes is a multifactorial disease resulting from the interaction of genetic and environmental factors and develops as a result of both insulin resistance and defects in insulin secretion. We have clearly demonstrated a role for Sox4 in glucose-stimulated insulin release in adult pancreatic beta-cells and in causing mild but significant glucose intolerance. It will be important to assess whether Sox4 has a role in contributing to type 2 diabetes in humans or to monogenic MODY type diabetes. Further characterization of the role of Sox4 in the adult beta-cell will aid us in understanding the complex picture of transcriptional regulation in this important cell.
###end p 75
###begin title 76
Supplementary Material
###end title 76
###begin title 77
Online-Only Appendix
###end title 77
###begin p 78
H.F. has received a studentship from the Medical Research Council. This work has received Diabetes U.K. Grant BDA:RD00/002072 and European Union FP6 Grant LHSM-CT-2003-503041.
###end p 78
###begin p 79
We thank the staff of the Mary Lyon Centre for their excellent technical support. We thank Stuart Townsend (Medical Research Council, Harwell) and Judith Sheldon (Oxford Brookes University) for assistance with electron microscopy.
###end p 79
###begin title 80
REFERENCES
###end title 80
###begin p 81
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Schematic of Sox4 gene structure and position of Sox4 mutations within the highly conserved HMG DNA binding domain.
###end p 81
###begin p 82
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Del</italic>
###xml 77 79 77 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">13</italic>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Svea36H</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 162 166 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 178 179 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 193 194 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 246 247 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 455 456 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 621 622 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 627 628 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 680 681 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 697 698 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 743 744 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1037 1038 1036 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
IGT4 embryos at 14.5 dpc. A: Wild-type embryo. B: Mutant IGT4 Sox4 Y123C/Del(13)Svea36H embryo showing severe edema. C and D: Transverse muMRI sections through a Sox4 wild-type (C) and mutant (D) embryo at the level of the AV valves at 14.5 dpc. C: In the wild-type embryo, the left (LV) and right (RV) ventricle are separated by the interventricular septum (IVS), and the left (LA) and right (RA) atrium are separated by the primary atrial septum (PAS). D: In a corresponding section of a mutant embryo, a ventricular septal defect (VSD) can be seen. The mitral valve (MV) and the tricuspidal valve (TV) are dysplastic. E and F: Three-dimensional reconstructions of a wild-type (E) and a mutant (F) heart at 14.5 dpc. In the wild-type heart (E), the aorta (Ao) originates from the left ventricle (LV), and the pulmonary artery (PA) originates from the right ventricle (RV). The left (LVOT) and right ventricular outflow tract (RVOT) are indicated. The PA connects to the descending aorta (dAo) via the ductus arteriosus. In the mutant (F), a ventricular septal defect (VSD) connects the LV and RV. The Ao and PA both originate from the RV (double-outlet right ventricle). The aortic arch (AoA) does not connect to the descending aorta (dAo), showing an interrupted aortic arch (IAoA). Note also the dilated PA. Axes: D, dorsal; V, ventral; A, anterior; P, posterior; L, left; R, right. (Please see  for a high-quality digital representation of this figure.)
###end p 82
###begin p 83
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 611 612 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 672 673 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 680 681 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 817 818 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 879 880 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 924 925 924 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 932 933 932 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1074 1078 1074 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1123 1127 1123 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 1183 1184 1183 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1195 1196 1195 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1212 1213 1212 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1233 1234 1233 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1267 1270 1267 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1326 1327 1326 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1467 1468 1467 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1473 1474 1473 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
###xml 1132 1136 <span type="species:ncbi:10090">mice</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
Plasma glucose measured in IPGTT in male mice at 12 weeks of age. A: Animals heterozygous for the Sox4Y123C mutation show impaired glucose tolerance (#P < 0.05) compared with wild-type littermates. The phenotype is exacerbated in mice also carrying a heterozygous insulin receptor (IR) knockout. Insulin receptor and Sox4 Y123C, purple squares, n = 20; IR+/- only, blue stars, n = 21; Sox4 Y123C, red circles, n = 15; wild-type littermates, black triangles, n = 15. B: Animals heterozygous for the Sox4S70P mutation show impaired glucose tolerance compared with wild-type littermates. Sox4S70P, green diamonds, n = 15; compared with wild-type littermate, black triangles, n = 23. C: Both lines exhibit significantly higher plasma glucose concentrations measured at 20 and 30 min of an IPGTT. Sox4 Y123C, red circles, n = 12; Sox4S70P, green diamonds, n = 9; IR only, blue stars, n = 9; wild-type littermate, black triangle, n = 24. D: Insulin secretion measured during a 30-min IPGTT. Both lines show impaired glucose stimulated insulin release. Statistical significance of Sox4 Y123C mice versus wild-type littermates and Sox4S70P mice versus wild-type littermates is indicated by *P < 0.05, **P < 0.01, and ***P < 0.001 (Student's t test). Insulin secretion from IR+/- mice was significantly different at all time points (##P < 0.01). Wild-type littermates from S70P and Y123P lines were not statistically significantly different from each other and were pooled in C and D. All data are expressed as means +/- SE.
###end p 83
###begin p 84
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 517 518 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 532 533 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 547 548 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
Insulin secretion from islets isolated from Sox4 Y123C mutant (black diagonal stripe bars), insulin receptor heterozygotes (black bars), and wild-type littermates (white bars) in response to glucose (0, 2, or 20 mmol/l) or 200 mumol/l tolbutamide (tol) normalized to total insulin content. Islets were isolated from five mice of each genotype. The data represent the mean of five animals (with three technical replicates per animal and each replicate comprising five islets +/- SE). Statistical analysis by Student's t test, where *P < 0.05 and **P < 0.01.
###end p 84
###begin p 85
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Immunohistochemistry on paraffin sections of 17-week-old pancreas. Images show wild-type and Sox4 heterozygous animals stained with insulin, glucagon, somatostatin, PDX1, Nkx-6.1, NeuroD1, MafA, and Glut-2 at x100 and x400 magnification. Sections were counterstained with Gill's formulation no. 2 hematoxylin. (Please see  for a high-quality digital representation of this figure.)
###end p 85
###begin p 86
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 617 621 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 657 658 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 680 681 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 688 691 687 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck</italic>
###xml 711 712 710 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 756 757 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 848 849 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 891 892 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 943 944 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 958 959 957 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
A and B: Quantitative PCR of corresponding RNAs from gene-specific knockdowns in Ins1 cells. A: Gck gene expression is markedly reduced in cells transfected with Gck siRNA compared with nonsense (ns) or Sox4 siRNA-transfected cells. B: Sox4 gene expression is markedly reduced in cells transfected with Sox4 siRNA compared with nonsense or Gck siRNA-transfected cells. Data represent the mean of three experimental (i.e., biological) replicates with three technical replicates of each. C: Insulin secretion in response to glucose (0, 2, or 20 mmol/l) or 200 mumol/l tolbutamide (Tol) from INS1 cells transfected with Sox4 siRNA (black diagonal stripe bars, n = 6; and black bars, n = 6), Gck siRNA (white bars, n = 6), or nonsense siRNA (cross hatch bars, n = 6). The data are the mean of three separate experiments each of six replicates of 1 x 105 cells. Statistical analysis by Student's t test compared with nonsense siRNA control, where *P < 0.05 and **P < 0.01.
###end p 86
###begin p 87
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Mean change in [Ca2+]i in response to 2, 5, 10, and 20 mmol/l glucose for mock-transfected (unfilled diamond) INS1 cells or INS1 cells transfected with nonsense (unfilled square), Sox4(1) (filled diamond), Sox4(2) (filled circle), or Gck (filled triangle) siRNA. Each data point is the mean of 14-24 cells. The data are representative of two separate experiments.
###end p 87
###begin p 88
Result of embryonic phenotype analysis and complementation tests
###end p 88
###begin p 89
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
Data are n. Males heterozygous for the Y123C Sox4 mutation were crossed to females heterozygous for the same mutation, the S70P mutation, and the Del(13)Svea36H deletion. Embryo dissections were carried out at 9.5, 13.5, and 14.5 dpc, and the embryonic phenotype was visually analyzed.
###end p 89
###begin p 90
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Pancreatic islet area in 17-week-old male mice
###end p 90
###begin p 91
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox4</italic>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
Data are n and percent. The pancreas was mounted longitudinally and serially sectioned with every 20th section stained with H-E, resulting in 10 sections from each of 3 mutant mice (Sox4Y123C) and 3 wild-type mice (60 whole sections).
###end p 91
###begin p 92
Arbitrary units based on pixel values.
###end p 92

